BC
AMED

Brookfield Corp’s Amedisys AMED Stock Holding History

Brookfield Corp’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60,000
Closed -$5.49M – 129
2023
Q2 		$5.49M Buy
+60,000
New +$4.92M 0.02% 252
2021
Q4 		– Sell
-9,994
Closed -$1.49M – 627
2021
Q3 		$1.49M Buy
+9,994
New +$2.08M 0.01% 385

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Brookfield Corp's AMED Position: Q3 2023 in Review

Brookfield Corp sold out of Amedisys (AMED) in Q3 2023, closing a stake of 60,000 shares — an estimated $5.49M sold.

Brookfield Corp first reported a position in AMED in Q3 2021 and held it in 2 quarters. The position peaked at $5.49M in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Brookfield Corp reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 60,000 Amedisys shares in Q3 2023, an estimated $5.49M.
  • Brookfield Corp first reported a position in Amedisys in Q3 2021 and held it in 2 quarters.
  • Brookfield Corp's Amedisys position peaked at $5.49M in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.